H19 and serous adenocarcinoma: Additionally, the involvement of H19 in platinum resistance was evidenced in a study of tissues obtained from 41 high-grade serous carcinoma patients treated with either cisplatin or carboplatin; the results revealed that H19 positively correlated with the early recurrence of OC [50].